Why the study?
TAVR explantation for a failing bioprosthesis appears rare, but its clinical impact is substantial.
What is the clinical impact of surgical explantation in patients with a failing transcatheter aortic bioprosthesis?
What is the clinical impact of surgical explantation in patients with a failing transcatheter aortic bioprosthesis?
Surgical explantation of failing TAVR valves is rare but carries substantial clinical impact, emphasizing the need for lifetime management strategies when selecting initial valve types for younger, lower-risk patients.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Yokoyama et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: